Compositions for reducing hypercholesterolemia and controlling of postprandial blood glucose and insulin levels

Details for Australian Patent Application No. 2001253392 (hide)

International Classifications

Event Publications

2 February 2006 Application Accepted

Published as AU-B-2001253392

2 February 2006 Change of Name(s) of Applicant(s), Section 104

Mid-America Commercialization Corporation The name of the applicant has been changed to National Institute for Strategic Technology Acquisition and Commercialization

1 June 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.